Moderna, Inc.
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
MRNA$250.83-6.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
(In millions, except per share data)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $2,595 | $1,927 |
| Investments | 3,204 | 5,098 |
| Accounts receivable, net | 184 | 358 |
| Inventory | 153 | 117 |
| Prepaid expenses and other current assets | 408 | 599 |
| Total current assets | 6,544 | 8,099 |
| Investments, non-current | 2,336 | 2,494 |
| Property, plant and equipment, net | 2,134 | 2,196 |
| Right-of-use assets, operating leases | 719 | 759 |
| Other non-current assets | 605 | 594 |
| Total assets | $12,338 | $14,142 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $317 | $405 |
| Accrued liabilities | 1,386 | 1,427 |
| Deferred revenue | 99 | 153 |
| Other current liabilities | 185 | 221 |
| Total current liabilities | 1,987 | 2,206 |
| Deferred revenue, non-current | 153 | 58 |
| Operating lease liabilities, non-current | 653 | 671 |
| Financing lease liabilities, non-current | 20 | 39 |
| Long-term debt | 590 | — |
| Other non-current liabilities | 285 | 267 |
| Total liabilities | 3,688 | 3,241 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001; 162 shares authorized as of December 31, 2025 and 2024; no shares issued or outstanding at December 31, 2025 and 2024 | — | — |
| Common stock, par value $0.0001; 1,600 shares authorized as of December 31, 2025 and 2024; 394 and 386 shares issued and outstanding as of December 31, 2025 and 2024, respectively | — | — |
| Additional paid-in capital | 1,382 | 866 |
| Accumulated other comprehensive income (loss) | 45 | (10) |
| Retained earnings | 7,223 | 10,045 |
| Total stockholders’ equity | 8,650 | 10,901 |
| Total liabilities and stockholders’ equity | $12,338 | $14,142 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.